In 2025, Sartorius Stedim Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Sartorius Stedim Biotech has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 |
|---|---|---|
Total Scope 1 | 16,026a | 13,682a |
Total Scope 2 | ||
Market-Based | 29,279a | 30,463a |
Location-Based | 47,401a | 44,558a |
Total Scope 3 | 403,532a | 385,918a |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 4.5936a | 4.7295a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Sartorius Stedim Biotech amounted to 63,427 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Sartorius Stedim Biotech increased by 8.91%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Sartorius Stedim Biotech were 16,026 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2024), Sartorius Stedim Biotech's Scope 1 emissions increased by 17.13%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Sartorius Stedim Biotech reported Scope 2 greenhouse gas (GHG) emissions of 29,279 tCO₂e using the market-based method and 47,401 tCO₂e using the location-based method.a
Compared to the previous year (2024), Sartorius Stedim Biotech's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Sartorius Stedim Biotech's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Sartorius Stedim Biotech reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Sartorius Stedim Biotech reported 403,532 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Sartorius Stedim Biotech includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Sartorius Stedim Biotech reported total Scope 3 emissions of 403,532 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 80.46% of these emissions originated from upstream activities such as purchased goods and capital goods, while 19.54% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2024), Sartorius Stedim Biotech's Scope 3 emissions remained relatively stable, indicating that Sartorius Stedim Biotech's emissions have plateaued with no significant change in its value chain footprint.a
In 2025, Sartorius Stedim Biotech reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to Sartorius Stedim Biotech's Scope 3 emissions were:a
In 2025, Sartorius Stedim Biotech reported Scope 1 greenhouse gas (GHG) emissions of 16,026 tCO₂e and total revenues of USD 3,489 millions. This translates into an emissions intensity of 4.59 tCO₂e per millions USD.a
In 2025, Sartorius Stedim Biotech reported a Scope 1 emissions intensity of 4.59 tCO₂e per millions USD. Compared to the peer group median of 5.09, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Sartorius Stedim Biotech ranked 12 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Sartorius Stedim Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2025, Sartorius Stedim Biotech reported a total carbon footprint of 466,959 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.13% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Sartorius Stedim Biotech's total carbon footprint was Scope 3 emissions, accounting for 86.42% of the company's total carbon footprint, followed by Scope 2 emissions at 10.15%.a